뉴스벤징가
Lyell Immunopharma Issues Colorectal Cancer Drug Safety Update
· 발표
기사 요약
Lyell Immunopharma reports improved safety data for LYL273 in metastatic colorectal cancer and advances study to Phase 1/2 design.
기사 원문에서 발췌했어요.Lyell Immunopharma reports improved safety data for LYL273 in metastatic colorectal cancer and advances study to Phase 1/2 design.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…